Skip to main content
Gelareh Zadeh on Muck Rack

Gelareh Zadeh

Rochester, Toronto
As seen in: Nature, Wiley Online Library, BioRxiv, Cell Press, Molecular Cancer Research
Chair & Prof, Dept of Neurological Surgery, Mayo Clinic Rochester William J and Charles H Mayo Professor Chief Medical Officer, Mayo Clinic Platform @MayoClinic
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gelareh

Contact Gelareh, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Spatially resolved single-cell analyses of human meningioma identify novel cell states influencing tumor microenvironment and progression

|
By Alexander Landry, Leeor S. Yefet, Justin Wang, Chloe Gui, Yosef Ellenbogen, Jeff Liu, Vikas Patil, Qingxia Wei, Sheila Mansouri, Olivia Singh, Aaron A Cohen-Gadol, Derek Tsang, Andrew F Gao, Kenneth Aldape, Farshad Nassiri, Gelareh Zadeh, Andrew Ajisebutu
| Nature Verified
Abstract Recent advances in our understanding of the molecular landscape of meningioma have generated new insights into the biology and heterogeneity of this disease, with demonstrated clinical value. However, there remains a need to understand tumor-intrinsic heterogeneity at single-cell resolution to inform potential therapeutic avenues.
Open in Who Shared Issue with article?

Multidisciplinary management of meningiomas in the era of precision oncology

|
By Majid Assadi, Malik E. Juweid, Philipp Lohmann, Giuseppe Minniti, Felix Sahm, Jana Ivanidze, Philipp Karschnia, Alexander Landry, Felix M. Mottaghy, Gelareh Zadeh
| Nature Verified
Abstract Meningiomas are the most common type of primary intracranial tumour. Histopathology-based WHO grading remains the standard for guiding management in most institutions, although new molecularly driven classification tools have been shown to improve prognostic accuracy and could guide personalized management decisions.
Open in Who Shared Issue with article?

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection - Nature Cancer

|
By Yong Zeng, Dor D Abelman, Althaf Singhawansa, Nicholas Cheng, Yuanchang Fang, Sasha C. Main, Emma J Bell, Wenbin Ye, Ping Luo, Samantha Wilson, Eric Y. Stutheit-Zhao, Derek Wong, Nadia Znassi, Kui Chen, Suluxan Mohanraj, Enrique Sanz-Garcia, Faiyaz Notta, anand Ghanekar, Philip Awadalla, Benjamin H. Lok, Michael Hoffman, Raymond Kim, Gelareh Zadeh, Scott V. Bratman, Mathieu Lupien, Trevor J. Pugh, Housheng Hansen He
| Nature Verified
Abstract Cell-free DNA analysis via methylation and fragmentation profiling has advanced minimally invasive cancer detection; however, broader application has been limited by small cohorts and inconsistent data processing. Here we collated 1,074 cfMeDIP-seq profiles across 9 studies, comprising cancer samples from 11 cancer types, carriers of Li-Fraumeni syndrome and healthy controls. We developed a uniform computational workflow to mitigate technical and biological confounders across cohorts.
Open in Who Shared Issue with article?
See all 14 articles